SCHEMBL20130973

SCHEMBL20130973

CC(C)(c1ccccccccc1)n1c2ccccc2c2cc3c4ccccc4n(-c4ccccccccc4)c3cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PPARG P37231 4/20 0.35
PPARA Q07869 2/20 0.35
MAPK8 P45983 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 1/20 0.35
GLA P06280 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
PGR P06401 2/20 0.34
MAPK9 P45984 1/20 0.34
PLA2G2A P14555 1/20 0.33
MAPT P10636 2/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15447708 0.87 KDM4E (0.56) KDM4EATML3MBTL1PPARGMAPK8
SCHEMBL15447716 0.82 KDM4E (0.58) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL15447692 0.82 KDM4E (0.58) KDM4EATML3MBTL1PPARGMAPK8
SCHEMBL13085549 0.81 GPR3 (0.44) KDM4EATML3MBTL1KMT2AALDH1A1
SCHEMBL6569796 0.81 L3MBTL1 (0.78) KDM4EATML3MBTL1MAPK8KMT2A
SCHEMBL30402523 0.81 L3MBTL1 (0.78) KDM4EATML3MBTL1MAPK8KMT2A
SCHEMBL12104983 0.81 KDM4E (0.56) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL10206249 0.79 KDM4E (0.55) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL10027594 0.79 L3MBTL1 (0.75) KDM4EATML3MBTL1MAPK8KMT2A
SCHEMBL10027584 0.79 L3MBTL1 (0.75) KDM4EATML3MBTL1MAPK8KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD. (CN) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT OCIAD1, OCIAD2, SRD5A1 KDM4E 2236/4885ATM 1986/4885L3MBTL1 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.